Skip to main content
Premium Trial:

Request an Annual Quote

Bayer, Rosetta Green Reach Deal to Improve Cotton Yields

NEW YORK (GenomeWeb News) – Rosetta Green and Bayer CropScience have signed an agreement directed at discovering and characterizing microRNA genes with the potential to improve cotton yields.

Specifically, the licensing deal announced today is directed at developing new cotton varieties that can produce improved yields under difficult environment, such as drought.

Bayer will have an exclusive license to targets identified by the collaboration toward better yields in cotton. Bayer will provide Rosetta development and commercialization milestone payments, as well as royalties based on future revenues from sales that could reach the tens of millions of dollars, the two firms said.

"We are hopeful that the new technology that Bayer and Rosetta Green will develop will succeed in significantly increasing cotton yields, especially in periods of drought and water shortage and in countries that suffer from chronic scarcity in potable water," Rosetta Green's CEO Amir Avniel said in a statement.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.